We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Compass Minerals
CMP
$1.24B
| $5.99M | 0.02% |
72,952
+12,899
| +21% | +$1.14M |
|
1002
MGE Energy Inc
MGEE
$3.11B
| $5.99M | 0.02% |
154,520
+13,182
| +9% | +$534K |
|
1003
ONE Gas
OGS
$5.05B
| $5.98M | 0.02% |
140,436
-11,256
| -7% | -$480K |
|
1004
Copa Holdings
CPA
$5.56B
| $5.97M | 0.02% |
72,281
-2,096
| -3% | -$200K |
|
1005
Royal Bank of Canada
RY
$291B
| $5.96M | 0.02% |
97,509
-4,290
| -4% | -$276K |
|
1006
Canadian Imperial Bank of Commerce
CM
$107B
| $5.96M | 0.02% |
161,746
-7,132
| -4% | -$275K |
|
|
DBD
1007
DELISTED
Diebold Nixdorf Incorporated
DBD
| $5.95M | 0.02% |
169,942
-51,902
| -23% | -$1.83M |
|
1008
Howard Hughes
HHH
$3.93B
| $5.94M | 0.02% |
+43,415
| New | +$6.18M |
|
1009
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
| $5.94M | 0.02% |
214,392
-2,744
| -1% | -$77.9K |
|
|
POLY
1010
DELISTED
Plantronics, Inc.
POLY
| $5.94M | 0.02% |
105,424
+29,854
| +40% | +$1.66M |
|
1011
Mueller Water Products
MWA
$3.92B
| $5.91M | 0.02% |
649,429
+8,212
| +1% | +$79.2K |
|
1012
Brown & Brown
BRO
$22.9B
| $5.91M | 0.02% |
359,540
-40,014
| -10% | -$654K |
|
1013
UGI
UGI
$8B
| $5.89M | 0.02% |
171,062
-232,307
| -58% | -$8.24M |
|
1014
Mueller Industries
MLI
$14.1B
| $5.89M | 0.02% |
678,716
-184,836
| -21% | -$1.65M |
|
1015
Cognex
CGNX
$10.3B
| $5.88M | 0.02% |
244,380
+195,794
| +403% | +$4.81M |
|
1016
Celanese
CE
$5.09B
| $5.84M | 0.02% |
81,277
-28,678
| -26% | -$1.91M |
|
|
FDO
1017
DELISTED
FAMILY DOLLAR STORES
FDO
| $5.84M | 0.02% |
74,102
-155,908
| -68% | -$12.3M |
|
1018
AMN Healthcare
AMN
$1.28B
| $5.84M | 0.02% |
184,770
-1,228
| -0.7% | -$32.1K |
|
1019
TC Energy
TRP
$73.5B
| $5.83M | 0.02% |
143,581
+2,371
| +2% | +$104K |
|
|
IPHS
1020
DELISTED
Innophos Holdings, Inc.
IPHS
| $5.82M | 0.02% |
110,577
+60,074
| +119% | +$3.26M |
|
1021
AstraZeneca
AZN
$263B
| $5.81M | 0.02% |
91,240
-4,354
| -5% | -$298K |
|
|
CDK
1022
DELISTED
CDK Global, Inc.
CDK
| $5.79M | 0.02% |
107,341
+21,903
| +26% | +$1.12M |
|
1023
Standex International
SXI
$3.68B
| $5.76M | 0.02% |
72,107
+55,101
| +324% | +$4.49M |
|
1024
Genesis Energy
GEL
$1.84B
| $5.75M | 0.01% |
+130,931
| New | +$6.18M |
|
1025
Commercial Metals
CMC
$7.63B
| $5.62M | 0.01% |
349,760
+37,731
| +12% | +$616K |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.